Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

Roche’s AI factories, protein design reasoning model, and healthcare robotics are among GTC announcements for biology.

Cayman advanced the protocol from a 1-L setup to a 100-L pilot run, operating the reaction and analysis independently.

Construction is already underway at Axplora's Farmabios HPAPI manufacuring facility in Italy, with completion targeted for February 2027.

The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

MilliporeSigma, the U.S. and Canadian Life sciences business of Merck KGaA, Darmstadt, Germany, has set out to establish a leading presence in organoid development, starting with its €104 million ...

AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.

A new technique combined with changes in material design is making reversible viscosity modulations possible, according to researchers from the University of Guelph in Ontario, Canada. By connecting ...

Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.